Medicare Enrolled

Dr. Sebastian Wilk, MD

Rheumatology · Olean, NY
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
OLEAN MEDICAL GROUP, Olean, NY 14760
7163762223
In practice since 2014 (12 years)
NPI: 1619389475 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Wilk from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Wilk? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Wilk

Dr. Sebastian Wilk is a rheumatology specialist in Olean, NY, with 12 years of NPI registration. Based on federal Medicare data, Dr. Wilk performed 4,651 Medicare services across 891 unique beneficiaries.

Between the years covered by Open Payments, Dr. Wilk received a total of $54,485 from 33 pharmaceutical and/or device companies across 557 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Wilk is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 12 years in practice ▲ Top 26% volume in NY $54,485 industry payments

Medicare Practice Summary

Medicare Utilization ↗
4,651
Medicare services
Top 26% in NY for rheumatology
891
Unique beneficiaries
$26
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~388 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Denosumab injection (Prolia/Xgeva) 1,920 $19 $29
Infliximab infusion (Remicade)
An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose.
1,310 $26 $89
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
345 $86 $208
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
133 $8 $11
Steroid injection (triamcinolone)
A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered.
130 $1 $7
Complete blood count (CBC) with differential
An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells.
129 $8 $50
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
91 $11 $67
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
69 $49 $162
Comprehensive metabolic blood panel
A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers.
59 $10 $72
Intravenous injection of additional new drug or substance
Administration of an additional new medication or substance directly into a vein.
57 $12 $48
Additional hour of intravenous chemotherapy
This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period.
53 $20 $57
Methylprednisolone injection, up to 125 mg
An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg.
53 $4 $7
Erythrocyte sedimentation rate (ESR) test
A blood test that measures how quickly red blood cells settle in a test tube to detect inflammation in the body. This specific method is performed manually rather than using an automated machine.
46 $4 $30
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
45 $96 $290
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
44 $104 $298
Normal saline infusion, 250 cc
Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid.
40 $0 $20
X-ray of hand, minimum of 3 views
An X-ray imaging test of the hand that captures at least three different angles to visualize the bones and joints.
29 $38 $57
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
22 $66 $149
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
22 $31 $160
Foot X-ray, 3+ views
An X-ray imaging test of the foot that captures at least three different views to evaluate the bones and joints.
19 $34 $59
Cardiac enzyme level (CK-MB) test
A blood test that measures the total level of creatine kinase, specifically the cardiac enzyme fraction, to help evaluate heart muscle damage.
13 $6 $24
Bone density scan (DEXA) of hip, pelvis, and spine
This test measures bone density in the hip, pelvis, and spine to assess bone strength. It also includes an assessment for spine fractures.
11 $50 $100
Trabecular bone score calculation
This procedure calculates the trabecular bone score using imaging data to assess bone microarchitecture. It includes interpretation and a report on fracture risk.
11 $31 $70
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
31.5% high complexity
49.5% medium
19.0% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$54,485
Total received (2018-2024)
Avg $7,784/year across 7 years
Top 10% in NY for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
33
Companies
557
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$37,507 (68.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,269 (18.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$6,709 (12.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$40,512
2023
$6,970
2022
$1,920
2021
$1,951
2020
$2,063
2019
$749
2018
$319

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$31,406
UCB, Inc.
$4,113
AstraZeneca Pharmaceuticals LP
$2,596
ABBVIE INC.
$1,605
Aurinia Pharma U.S., Inc.
$204
Janssen Biotech, Inc.
$151
Mallinckrodt Hospital Products Inc.
$125
Boehringer Ingelheim Pharmaceuticals, Inc.
$57
Daiichi Sankyo Inc.
$53
Novartis Pharmaceuticals Corporation
$44
E.R. Squibb & Sons, L.L.C.
$40
Alexion Pharmaceuticals, Inc.
$34
CSL Behring
$33
PFIZER INC.
$31
SOBI, INC
$20
Top 3 companies account for 94.1% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$32,755
Horizon Therapeutics plc
$4,946
UCB, Inc.
$4,907
AstraZeneca Pharmaceuticals LP
$3,285
ABBVIE INC.
$1,777
Mallinckrodt Hospital Products Inc.
$1,150
GlaxoSmithKline, LLC.
$884
Lilly USA, LLC
$712
Boehringer Ingelheim Pharmaceuticals, Inc.
$614
PFIZER INC.
$587
AbbVie Inc.
$585
Janssen Biotech, Inc.
$463
Aurinia Pharma U.S., Inc.
$417
Genentech USA, Inc.
$314
Janssen Scientific Affairs, LLC
$226
GENZYME CORPORATION
$146
E.R. Squibb & Sons, L.L.C.
$107
AbbVie, Inc.
$90
Novartis Pharmaceuticals Corporation
$80
Novo Nordisk Inc
$76
Alexion Pharmaceuticals, Inc.
$60
Daiichi Sankyo Inc.
$53
Sandoz Inc.
$42
CSL Behring
$33
Fresenius Kabi USA, LLC
$24
Actelion Pharmaceuticals US, Inc.
$23
Celgene Corporation
$22
SOBI, INC
$20
Merck Sharp & Dohme LLC
$20
Regeneron Pharmaceuticals, Inc.
$17
Pharming Healthcare, Inc.
$17
Mallinckrodt Enterprises LLC
$17
Exeltis, USA Inc.
$15
Top 3 companies account for 78.2% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · BENLYSTA · Bimzelx · COSENTYX · CYLTEZO · Cimzia · EVENITY · EVUSHELD · Enbrel · HUMIRA · HYRIMOZ · Hizentra · Humira · IDACIO · ILARIS · INFLECTRA · INJECTAFER · JARDIANCE · KEVZARA · KINERET · KRYSTEXXA · LUPKYNIS · OFEV · ORENCIA · Otezla · Ozempic · PNEUMOVAX 23 · PURIFIED CORTROPHIN GEL · Prolia · RAYOS · REMICADE · RHEUMATOID ARTHRITIS DISEASE · RINVOQ · RUCONEST · Rinvoq · Rituxan · Rybelsus · SAPHNELO · SIMPONI ARIA · SKYRIZI · STELARA · STRENSIQ · Soliris · Strensiq · TALTZ · TAVNEOS · TREMFYA · UPTRAVI · XELJANZ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (69%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in rheumatology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 10% for rheumatology in NY.

Looking for a rheumatology specialist in Olean?
Compare rheumatologists in the Olean area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists within 10 mi
2
Per 100K population
2.6
County median income
$58,248
Nearest hospital
OLEAN GENERAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Wilk is a mixed practice specialist, with above-average Medicare volume (top 26% in NY), with speaking/promotional industry engagement in the top 10% of NY peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Wilk experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Wilk performed 1,920 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Wilk receive payments from pharmaceutical companies?
Yes. Dr. Wilk received a total of $54,485 from 33 companies across 557 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Wilk's costs compare to other rheumatologists in Olean?
Dr. Wilk's average Medicare payment per service is $26. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Wilk) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →